| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 1324 | 124 | 159 | 18 |
Cancer, Oncogene, Cancer research, Cell cycle and Molecular medicine are the subjects of interest in the journal. It explores issues in Cancer which can be linked to other research areas like Immunohistochemistry, Lung cancer and Pathology. The works on Pathology deal in particular with Carcinoma.
In addition to Oncogene research, the journal aims to explore topics under Colorectal cancer, microRNA, Breast cancer and Gene knockdown. While the primary focus in the journal is Cancer research, it also dissects topics surrounding Protein kinase B and PI3K/AKT/mTOR pathway as a whole. Topics in Cell cycle explored in it were investigated in conjunction with research in Molecular biology, Cell culture and Cell growth.
The journal addresses concerns in Molecular medicine which are intertwined with other disciplines, such as Biomarker (medicine), Hepatocellular carcinoma and Survival analysis. The concepts on Cell presented in it can also apply to other research fields, including Signal transduction, Cell biology and Transfection. Some problems in Internal medicine that were presented in the journal overlapped with concepts under Gastroenterology and Oncology.
The most cited articles aim to foster the development of research in Cancer, Oncogene, Cancer research, Cell cycle and Pathology. The Cancer studies which were featured in the published papers aim to expound on the research in Internal medicine. The featured Oncogene studies in the published articles mainly concentrate on Molecular medicine but also cover areas of interest in Biomarker (medicine) and Hepatocellular carcinoma.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Oncology Letters (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Oncology Letters (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 14.84% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 14.88% were posted by at least one author from the top 10 institutions publishing in the journal. Another 15.79% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 20.33% of all publications and 49.00% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
While delving into the fascinating findings and insights from Oncology Letters, it's crucial not to overlook the potential career paths that this research can guide us towards. The field of oncology is a critical sector in healthcare, where research scientists, clinical scientists, and nurses play an integral part in making groundbreaking discoveries.
A career in oncology research offers an opportunity to contribute to the ongoing battle against cancer. Such a career path could lead to roles such as an Oncology Research Scientist who explores and investigate novel cancer treatments, or a Clinical Scientist specializing in cancer genetics, fostering the development of personalized cancer therapies.
For those interested in a direct patient care role within the oncology field, becoming an Oncology Nurse is an impactful choice. These roles often require specific nursing licenses per state. For instance, fulfilling the mississippi nursing license requirements would be an excellent first step for those aspiring to work in that area.
In any case, whether it's exploring biomarkers or creating innovative treatment strategies, pursuing a career in oncology research is a rewarding and fulfilling path, which truly embodies the spirit of these Oncology Letters topics. Remember, behind every line of research lies a team of dedicated professionals working together to make these significant discoveries.
Rodney Hull;Mzwandile Mbele;Tshepiso Makhafola;Chindo Hicks
(2020)Konstantinos Tsamakis;Maria Gavriatopoulou;Dimitrios Schizas;Athina Stravodimou
(2020)Lennart Hardell;Michael Carlberg
(2020)Valeska Moentenich;Florian Gebauer;Erdem Comut;Armin Tuchscherer
(2020)Naohiko Yoshizawa;Kazushi Sugimoto;Masahiko Tameda;Yuji Inagaki
(2020)Satoshi Inoue;Takumi Tsunoda;Miho Riku;Hideaki Ito
(2020)Mushi Ye;Huanshu Tian;Shanhong Lin;Jierong Mo
(2020)Junji Akagi;Hideo Baba
(2020)For those interested in healthcare but looking beyond traditional medical school, there are several online degree options that can pave the way for rewarding careers in the medical field. Programs like online rad tech programs offer a cost-effective path to becoming radiologic technologists, essential professionals who support diagnostic imaging processes.
If nutrition and wellness are your passion, dietetic masters programs provide advanced study options to become registered dietitians, a growing field with diverse clinical and community opportunities.
The healthcare industry also values skilled support staff. medical assistant programs allow students to earn credentials online, often with financial aid, facilitating entry into clinics, hospitals, and private practices.
For medical assistants seeking career advancement, the ma to lpn bridge program online is an excellent route to becoming licensed practical nurses, combining flexibility with hands-on training to expand clinical responsibilities.
